Current stock page

Catalysts

HAE Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - DevicesScore data as of Nov 18, 2026

HAEHaemonetics Corporation

Healthcare / Medical - Devices

Leader

Sector Leader

BullishEdge 10/10
$122.86+$1.94 (+1.60%)

Latest quote

  • Momentum
    91
  • Value
    60
  • Quality
    77
  • Risk resilience
    67
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 4, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 77/100

Momentum 91/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 18, 2026 · Sentiment 53.12%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 91/100AIQ Edge 10/10 Sector Leader
Beat rate
100%
8 of 8 reported periods
Average surprise
+4.9%
Across covered historical reports
Latest result
+4.7%
Nov 5, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 5, 2026—$1.29$1.35+4.7%$345.15M$357.76M
Aug 6, 2026—$1.08$1.14+5.6%$327.86M$339.38M
May 7, 2026—$1.28$1.29+0.8%$336.83M$346.35M
Feb 5, 2026—$1.27$1.31+3.1%$331.92M$339M
Nov 6, 2025—$1.12$1.27+13.4%$329.77M$327.32M
Aug 7, 2025—$1.01$1.10+8.9%$320.01M$321.39M
May 8, 2025—$1.22$1.24+1.6%$312.47M$330.6M
Feb 6, 2025—$1.18$1.19+0.8%$354.46M$348.54M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
10
Buy
2
Hold
12-month analyst target
$140.17
+14.09% versus current price
Based on 12 analyst observations. Targets are estimates, not predictions.
Low target
$119.00
-3.14% vs latest price
Average target
$140.17
+14.09% vs latest price
High target
$165.00
+34.30% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 4, 2027

Next known earnings or reporting date.

EPS estimate$1.26

Current analyst expectation for the upcoming report.

Revenue estimate$357.85M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score91

Where event reaction would show up first.

AIQ score77/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
12
Average target
$140.17
Target upside
14.09%
Target range
$119.00 - $165.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
1
Negative
0
seekingalpha.com · Nov 5, 2026

Haemonetics Corporation 2027 Q2 - Results - Earnings Call Presentation (NYSE:HAE) 2026-11-05

2026-11-05. The following slide deck was published by Haemonetics Corporation in conjunction with their 2027 Q2 earnings call.

seekingalpha.com · Nov 5, 2026

Haemonetics outlines FY 2027 organic growth of 6%-9% while scaling CSL Persona PLUS rollout through calendar 2027 (NYSE:HAE)

Haemonetics Q2 FY2027 earnings: raised revenue growth outlook, CSL rollout progress, and margin headwinds.

insidermonkey.com · Oct 28, 2026

Haemonetics Corporation (HAE) Gains on Strong Plasma Growth and Higher Guidance, Ariel Appreciation Fund Says

Ariel Investments, an investment management company, released its "Ariel Appreciation Fund" Q3 2026 investor letter. A copy of the letter can be downloaded here. Copy main article 1st para.

gurufocus.com · Oct 17, 2026

Haemonetics Corporation (HAE) -- Earnings Beat and Growth Potential | Ariel Appreciation Fund Q3 2026

Reported stronger-than-expected growth in the plasma business.Increased full-year guidance reflects confidence in operational performance.Challenges remain in t

Open full news and sentiment

HAE Catalysts FAQ

What are the next catalysts for HAE stock?

HAE's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move HAE stock?

Upcoming events that could move HAE include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could HAE's next earnings report affect the stock?

HAE's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive HAE stock higher?

HAE could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt HAE stock?

HAE could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.